EAM
AQST icon

Everstar Asset Management’s Aquestive Therapeutics AQST Stock Holding History

Everstar Asset Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Buy
611,943
+58,762
+11% +$247K 1.23% 11
2026
Q1 		$2.3M Buy
553,181
+208,381
+60% +$846K 1.22% 14
2025
Q4 		$2.23M Sell
344,800
-23,489
-6% -$146K 1.19% 19
2025
Q3 		$2.06M Sell
368,289
-290,318
-44% -$1.26M 1.17% 21
2025
Q2 		$2.18M Buy
658,607
+358,607
+120% +$1.03M 1.33% 15
2025
Q1 		$870K Buy
300,000
+83,777
+39% +$254K 0.58% 45
2024
Q4 		$770K Sell
216,223
-183,902
-46% -$848K 0.54% 49
2024
Q3 		$1.99M Buy
+400,125
New +$1.56M 1.37% 14

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Everstar Asset Management's AQST Position: Q2 2026 in Review

Everstar Asset Management increased its Aquestive Therapeutics (AQST) stake by 11% in Q2 2026, buying an estimated $247K and bringing the position to 611,943 shares worth $2.55M. The position accounts for 1.23% of the portfolio, ranked #11.

Everstar Asset Management first reported a position in AQST in Q3 2024 and has held it in 8 quarters since. 185 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Everstar Asset Management held 611,943 shares of Aquestive Therapeutics worth $2.55M as of Q2 2026.
  • Everstar Asset Management bought 58,762 Aquestive Therapeutics shares in Q2 2026, an estimated $247K.
  • Aquestive Therapeutics made up 1.23% of Everstar Asset Management's portfolio in Q2 2026, its #11 holding.
  • Everstar Asset Management first reported a position in Aquestive Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 185 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Everstar Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.